Literature DB >> 36147085

Medication non-compliance: A challenge in treating hypertension in Nepal.

Saral Lamichhane1, Amrit Pokhrel2, Nava Raj Sharma3.   

Abstract

Entities:  

Year:  2022        PMID: 36147085      PMCID: PMC9486534          DOI: 10.1016/j.amsu.2022.104362

Source DB:  PubMed          Journal:  Ann Med Surg (Lond)        ISSN: 2049-0801


× No keyword cloud information.
With the epidemiological transition, the burden of non-communicable diseases especially cardiovascular diseases is increasing in low- and middle-income countries (LMICs) like Nepal [1]. National level studies have reported the prevalence of hypertension between 20% and 32% in Nepal [[2], [3], [4]]. It is one of the most frequently encountered condition either in isolation or as a comorbidity in patients visiting the healthcare facilities. In Nepal, studies have shown that nearly half of the patients are aware of their condition, less than a half of them receive appropriate medications and among these treated patients also, only about half have optimal control of hypertension [4,5]. Noncompliance of medicine results in poorly controlled blood pressure even among the treated patients for hypertension [6]. Nearly 52% patients under treatment were found to have poor compliance with antihypertensive medicine in a study from Nepal [7]. This leads to increased risk of end-organ damage and complications like coronary artery diseases, cerebrovascular accidents, hypertensive retinopathy, nephropathy and peripheral vascular diseases [8]. Several patients suffer from functional decline and premature mortality contributing to increased disability adjusted life years (DALYs) and disease burden. Difficulties are encountered both during initiation as well as continuation of antihypertensive medicines in patients. Several factors like asymptomatic state on presentation (which patients misperceive as non-urgent), lack of awareness of long-term complications, fear of lifelong use of medicine when started, use of herbal remedies, etc. may hinder on initiation of drug therapy while other factors like increased cost on regular use, forgetfulness, feeling of wellness after some days of therapy and loss to follow-up can contribute to discontinuation of treatment [9,10]. The socioeconomic impact caused by COVID-19 pandemic [11] has also contributed to treatment noncompliance recently. The need for proper counseling by healthcare providers on hypertension, its possible complications, management options including antihypertensive medicines and their effectiveness to decrease long term complications cannot be stressed more. Public awareness is a vital factor. Supportive family members and caregivers can also play an important role. Newer approaches including community-based interventions, use of appropriate technology like mobile phone alerts can be adopted to improve patient compliance [12]. Health insurance policy can be one way of reducing financial burden due to regular long-term medications. This will not only benefit a large number of patients to maintain their health status and quality of life but also decreases the burden from possible complications on their family and society. Timely intervention with a holistic approach should be adopted to combat this issue from stakeholders at all levels.

Ethical approval

Not applicable.

Source of funding

None.

Author contribution

SL, AP, NRS were involved in designing, literature review writing and approving the final manuscript.

Research registration number

1. Name of the registry: Not required. 2. Unique Identifying number or registration ID: Not required. 3. Hyperlink to your specific registration (must be publicly accessible and will be checked):

Guarantor

Saral Lamichhane.

Consent

Not applicable.

Declaration of competing interest

None.
  10 in total

Review 1.  Non-adherence to anti-hypertensive medication in low- and middle-income countries: a systematic review and meta-analysis of 92443 subjects.

Authors:  J Ø Nielsen; A D Shrestha; D Neupane; P Kallestrup
Journal:  J Hum Hypertens       Date:  2016-06-16       Impact factor: 3.012

2.  Hypertension in the elderly.

Authors:  Nikolaos Lionakis; Dimitrios Mendrinos; Elias Sanidas; Georgios Favatas; Maria Georgopoulou
Journal:  World J Cardiol       Date:  2012-05-26

Review 3.  Burgeoning burden of non-communicable diseases in Nepal: a scoping review.

Authors:  Shiva Raj Mishra; Dinesh Neupane; Parash Mani Bhandari; Vishnu Khanal; Per Kallestrup
Journal:  Global Health       Date:  2015-07-16       Impact factor: 4.185

4.  Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal.

Authors:  Surya Devkota; Raja Ram Dhungana; Achyut Raj Pandey; Bihungum Bista; Savyata Panthi; Kartikesh Kumar Thakur; Ratna Mani Gajurel
Journal:  Front Cardiovasc Med       Date:  2016-08-02

5.  Prevalence and determinants of hypertension among adult population in Nepal: Data from Nepal Demographic and Health Survey 2016.

Authors:  Mehedi Hasan; Ipsita Sutradhar; Tahmina Akter; Rajat Das Gupta; Hemraj Joshi; Mohammad Rifat Haider; Malabika Sarker
Journal:  PLoS One       Date:  2018-05-31       Impact factor: 3.240

Review 6.  Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension in Nepal between 2000 and 2025: A Systematic Review and Meta-Analysis.

Authors:  Raja Ram Dhungana; Achyut Raj Pandey; Nipun Shrestha
Journal:  Int J Hypertens       Date:  2021-03-02       Impact factor: 2.420

7.  Effectiveness and Acceptability of a Mobile Phone Text Messaging Intervention to Improve Blood Pressure Control (TEXT4BP) among Patients with Hypertension in Nepal: A Feasibility Randomised Controlled Trial.

Authors:  Buna Bhandari; Padmanesan Narasimhan; Rohan Jayasuriya; Abhinav Vaidya; Aletta E Schutte
Journal:  Glob Heart       Date:  2022-02-23

Review 8.  Prevalence, awareness, risk factors and control of hypertension in Nepal from 2000 to 2020: A systematic review and meta-analysis.

Authors:  Dhan Bahadur Shrestha; Pravash Budhathoki; Yub Raj Sedhai; Abinash Baniya; Sandesh Lamichhane; Manoj Shahi; Bibodh Jung Karki; Ramkaji Baniya; Nimesh Patel
Journal:  Public Health Pract (Oxf)       Date:  2021-04-20

Review 9.  The socio-economic implications of the coronavirus pandemic (COVID-19): A review.

Authors:  Maria Nicola; Zaid Alsafi; Catrin Sohrabi; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Maliha Agha; Riaz Agha
Journal:  Int J Surg       Date:  2020-04-17       Impact factor: 6.071

10.  Prevalence of non-communicable diseases risk factors and their determinants: Results from STEPS survey 2019, Nepal.

Authors:  Bihungum Bista; Meghnath Dhimal; Saroj Bhattarai; Tamanna Neupane; Yvonne Yiru Xu; Achyut Raj Pandey; Nick Townsend; Pradip Gyanwali; Anjani Kumar Jha
Journal:  PLoS One       Date:  2021-07-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.